🔎 Trials Near Me

홈 › 신장암 (신세포암) › 캘리포니아

캘리포니아의 신장암 (신세포암) 임상 시험

신장암 (신세포암) 관련 연구 51개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, San Diego
  • Research Site, Santa Monica
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

  • NEO-811 Los Angeles Site, Duarte
  • NEO-811 San Diego Site, San Diego
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07300241

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

  • UCSF Medical Center at Mission Bay ( Site 5008), San Francisco
피험자 모집 중1/2상
18세 ~ 120세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07049926

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • University of California San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • 외 20개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #59, Santa Barbara
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  • University of California Irvine, Orange
  • Stanford, Palo Alto
  • University of California San Francisco, San Francisco
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05287945

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT03866382

DESTINY-PANTUMOUR04

  • Research Site, San Diego
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  • Local Institution - 0178, Palo Alto
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07293351

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

  • University of California San Diego, La Jolla
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • PCR Oncology, Arroyo Grande
  • Tower Cancer Research Foundation, Beverly Hills
  • Mills-Peninsula Medical Center, Burlingame
  • 외 16개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
  • City of Hope Investigational Drug Services (IDS), Duarte
  • UC San Diego Medical Center - Encinitas, Encinitas
  • 외 13개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07227415

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

  • USC Norris Comprehensive Cancer Center, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04969315

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • City of Hope Medical Center, Duarte
  • University of California San Diego Medical Center, Moores Cancer Center, La Jolla
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of California, San Diego, La Jolla
  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Redwood City, Redwood City
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • Sutter Auburn Faith Hospital, Auburn
  • Tower Cancer Research Foundation, Beverly Hills
  • City of Hope Comprehensive Cancer Center, Duarte
  • 외 23개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06661720

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

  • City of Hope Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05830058

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06432036

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

  • City of Hope National Medical Center, Duarte
  • Chao Family Comprehensive Cancer Center, Orange
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT05361720

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • Community Cancer Institute, Clovis
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Hoag Memorial Hospital Presbyterian, Newport Beach
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

  • City of Hope Medical Center, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07226544

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  • Providence Medical Foundation ( Site 0141), Fullerton
  • USC Norris Comprehensive Cancer Center ( Site 0126), Los Angeles
  • Cedars-Sinai Medical Center ( Site 0112), Los Angeles
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT07227402

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Duarte
  • Xencor Investigative Site, Sacramento
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Glendale
  • California Research Institute, Los Angeles
  • 외 3개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT04198766

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

  • University of California, San Francisco, San Francisco
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07043608

Imaging of Solid Tumors Using 18F-TRX

  • University of California, San Francisco, San Francisco
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06942104

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

  • City of Hope Medical Center, Duarte
  • City of Hope Medical Center, Irvine
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT07128680

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • John Wayne Cancer Institute (JWCI), Santa Monica
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 9. 업데이트됨 · NCT03972657

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

  • University of California, Davis, Sacramento
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 30. 업데이트됨 · NCT06101290

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

  • Start Lacn, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT07517198

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

  • City of Hope Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 9. 업데이트됨 · NCT07037004

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA Department of Medicine, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT06026410

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

  • City of Hope, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 20. 업데이트됨 · NCT06053658

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.